Hochschulschrift
Inhibition of ABC-transporters by plant secondary metabolites in multidrug-resistant cancer cells : importance of synergistic drug combinations
- Sprache
-
Englisch
- Umfang
-
X, 120 S.
- Maße
-
30 cm
- Anmerkungen
-
graph. Darst.
Heidelberg, Univ., Diss., 2012
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Klassifikation
-
Medizin, Gesundheit
Chemie
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Molecular targeting of metastatic and multidrug resistant cancers
Transfer of multidrug-resistant pathogens between humans and animals
The Search for Novel Effective Agents Against Multidrug-Resistant Enterobacteriaceae
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
Curbing multidrug-resistant bacteria with novel host defense peptide fragments
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Intestinal carriage of multidrug-resistant bacteria among healthcare professionals in Germany
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Molecular targeting of metastatic and multidrug resistant cancers
Transfer of multidrug-resistant pathogens between humans and animals
The Search for Novel Effective Agents Against Multidrug-Resistant Enterobacteriaceae
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
Curbing multidrug-resistant bacteria with novel host defense peptide fragments
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
Intestinal carriage of multidrug-resistant bacteria among healthcare professionals in Germany
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Molecular targeting of metastatic and multidrug resistant cancers
Transfer of multidrug-resistant pathogens between humans and animals
The Search for Novel Effective Agents Against Multidrug-Resistant Enterobacteriaceae
Tuberculosis out of control : strategies to fight multidrug-resistant tuberculosis
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
Curbing multidrug-resistant bacteria with novel host defense peptide fragments
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement